Cardiac Glycosides Part II: Pharmacokinetics and Clinical Pharmacology
The pharmacokinetics of digitalis glycosides have been the subject of extensive re view (IISALO, 1977; ARONSON, 1980; PERRIER et ai., 1977). Research on glycoside kinetics has progressed at a rapid pace, requiring continuing reevaluation of the state of our understanding of this problem. The presen...
| Corporate Author: | |
|---|---|
| Format: | eBook |
| Language: | English |
| Published: |
Berlin, Heidelberg
Springer Berlin Heidelberg
1981, 1981
|
| Edition: | 1st ed. 1981 |
| Series: | Handbook of Experimental Pharmacology
|
| Subjects: | |
| Online Access: | |
| Collection: | Springer Book Archives -2004 - Collection details see MPG.ReNa |
Table of Contents:
- Pharmacokinetics — Distribution, Metabolism, and Elimination
- 1 Pharmacokinetics of Digitoxin
- 2 Pharmacokinetics of Digoxin and Derivatives
- 3 Pharmacokinetics of Strophanthus Glycosides
- 4 Pharmacokinetics of Squill Glycosides
- Pharmacokinetics — Additional Pharmacokinetic Parameters of Cardiac Glycosides
- 5 Plasma Protein Binding of Cardiac Glycosides
- 6 Intestinal Absorption and Secretion of Cardiac Glycosides
- 7 Cardiac Uptake and Binding of Cardiac Glycosides
- 8 Bioavailability of Cardiac Glycosides
- 9 Pharmaceutical Quality Control Standards for Cardiac Glycosides
- Clinical Pharmacology
- 10 Effects of Cardiac Glycosides on the Failing and Nonfailing Heart
- 11 The Effect of Disease on Cardiac Glycoside Pharmacokinetics
- 12 Clinical Indications and Choice of Cardiac Glycosides, Clinical Conditions Influencing Glycoside Effects
- 13 Side Effects and Intoxication of Cardiac Glycosides: Manifestations and Treatment
- 14 Interactions Between Cardiac Glycosides and Other Substances in the Body
- Author Index